Skip to main content
. Author manuscript; available in PMC: 2013 Sep 30.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e391–e398. doi: 10.1016/j.ijrobp.2011.06.1961

Table 2.

Association Between Variables and Brachial Plexopathy

Characteristics With
Plexopathy
Total OR 95% CI P Value
Brachial Plexus Dose
 Max dose to 0.1 cm3 >75 Gy 5 16 3.283 0.925-11.646 0.056
≤75 Gy 9 74
 Max dose to 0.5 cm3 >75 Gy 3 13 1.800 0.427-7.593 0.419
≤75 Gy 11 77
 Max. dose to 1.0 cm3 >75 Gy 3 12 2.030 0.474-8.689 0.332
≤75 Gy 11 78
 Max. dose to 2.0 cm3 >75 Gy 3 7 4.909 0.966-24.952 0.038
≤75 Gy 11 83
 Median dose >69 Gy 3 5 10.091 1.512-67.331 0.005
≤69 Gy 11 85
Plexopathy before radiation Yes 5 13 4.722 1.267-17.606 0.021
No 9 77
Sex Male 8 49 1.138 0.360-3.597 0.825
Female 6 41
Body mass index >25 4 47 0.291 0.084-1.011 0.052
≤25 10 43
Diabetes Yes 2 15 0.808 0.161-4.047 0.795
No 12 75
Concurrent chemotherapy Yes 13 81 1.529 0.176-13.286 0.700
No 1 9

Abbreviations: OR, odds ratio; CI, confidence interval.